EP2914734A1 - Process for the enzymatic formation of amide bonds - Google Patents

Process for the enzymatic formation of amide bonds

Info

Publication number
EP2914734A1
EP2914734A1 EP13773248.3A EP13773248A EP2914734A1 EP 2914734 A1 EP2914734 A1 EP 2914734A1 EP 13773248 A EP13773248 A EP 13773248A EP 2914734 A1 EP2914734 A1 EP 2914734A1
Authority
EP
European Patent Office
Prior art keywords
mixture
alkyl
aqueous buffer
alkylaryl
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13773248.3A
Other languages
German (de)
French (fr)
Inventor
Steffen Osswald
Martin BINDL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Publication of EP2914734A1 publication Critical patent/EP2914734A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids

Definitions

  • the present invention is concerned with the formation of amide bonds with the aid of proteases in general.
  • One aspect of the present invention further, relates to the protease mediated synthesis of organogellant compounds (OG) as depicted below
  • L is a linking moiety of molecular weight from 14 g/mol to 500 g/mol, one of X 1 , X 2 is nitrogen and the other is carbon, and wherein R 1 are sidechain substituents.
  • Organogellant compounds as depicted above are known in the art to serve as gellants to thicken liquid compositions. Such gellants have, for example, been described in WO 201 1 /1 12912 A1 and WO 201 1 /1 12887 A1 .
  • Organogellant compounds also termed organogellants herein, in general are used to provide structure and a pleasant texture to liquid consumer products such as, for example, liquid detergent compositions. Furthermore, organogellants can be used to stabilize other components within such compositions such as, for example, enzymes and bleaches. However, organogellants need to be selected carefully for their respective application in order to prevent incompatibilities between organogellant and other components as well as unwanted side effects such as clouding.
  • Organogellants of the present invention offer significant advantages over other gellants currently in use, such as being compatible with a broad range of consumer products as well as not affecting product clarity.
  • amino acid esters connected via an amide bond on their amino terminus to nicotinic acid (pyridine-3-carboxylic acid )or isonicotinic acid (pyridine-4-carboxylic acid ) result in better yields during protease mediated coupling to amino compounds than amino acid esters carrying other moieties on their amino terminus such as for example typical protecting groups Benzoyl- or Z- (Carboxybenzyl).
  • Protease mediated amide bond formation employing amino acid esters connected via an amide bond on their amino terminus to nicotinic acid or isonicotinic acid, accordingly, provides efficient access to organogellants and peptides.
  • R 1 and R 2 are independently selected from hydrogen atom, Ci-C 4 alkyl, Ci-C 4 hydroxyalkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20
  • L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl;
  • X and Y are independently selected from -OH, -NH 2 , -NHR 3 , -NR 3 R 4 ;
  • R 3 and R 4 are independently selected from C1-C6 alkyl and C 7 -C20 alkylaryl; n is selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20;
  • R A is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl.
  • An alkyl is a linear, branched, or cyclic hydrocarbon chain. It may also be a combination of linear, branched, and cyclic hydrocarbon chains.
  • a C n -C m alkyl is an alkyl having n to m carbon atoms.
  • An aryl is an aromatic hydrocarbon.
  • An aryl may be monocyclic or polycyclic. In the case of polycyclic aryls, the individual aromatic rings may be fused or may be connected by single carbon-carbon bonds. Examples of suitable aryls are phenyl, biphenyl, naphtyl, anthryl, or phenanthryl.
  • a C n -C m aryl is an aryl having n to m carbon atoms.
  • a heteroaryl is an aromatic hydrocarbon that contains 1 to 4 heteroatoms, preferably 1 to 2 heteroatoms. Heteroatoms are independently selected from nitrogen, oxygen, sulfur.
  • a heteroaryl may be monocyclic or polycyclic.
  • a heteroaryl may be attached to the main molecule through any of its carbon or nitrogen atoms.
  • a C n -C m heteroaryl is a heteroaryl having n to m carbon atoms and 1 to 4 heteroatoms.
  • An alkylaryl is an aryl that is substituted with one or more alkyls.
  • An alkylaryl may be attached to the remainder of the molecule through any of its alkyl or aryl carbon atoms.
  • a C n -C m alkylaryl contains n to m carbon atoms.
  • An a Iky I heteroaryl is a heteroaryl that is substituted with one or more alkyls.
  • the alkyl substituents may be attached to the heteroaryl through any of the carbon- or heteroatoms of the heteroaryl.
  • the alkylheteroaryl group may be attached to the remainder of the molecule through any of the alkyl carbon atoms and/or the heteroaryl carbon- or heteroatoms.
  • a hydroxyalkyl is an alkyl carrying one or more hydroxyl groups.
  • hydroxyalkyl group contains n to m carbon atoms.
  • a thioether is a moiety wherein two alkyls are linked by a thioether bond.
  • a C n -C m thioether group contains n to m carbon atoms in total. The thioether group may be attached to the remainder of the molecule through any of its carbon atoms.
  • An alkylhydroxyaryl is an alkylaryl, carrying hydroxyl groups on any of the aryl carbon atoms.
  • the alkylhydroxyaryl group may be attached to the remainder of the molecule through any of its alkyl and/or aryl carbon atoms.
  • a C n -C m alkylhydroxyaryl contains n to m carbon atoms.
  • An alkyl-C(O)Y is an alkyl carrying a C(O)Y-group, wherein C(O) is a carbonyl function and Y is selected from -OH, -NH 2 , -NHR 3 , -NR 3 R 4 ; and wherein R 3 and R 4 are independently selected from C1-C6 alkyl and C7-C20 alkylaryl.
  • a C n -C m alkyl- C(O)Y contains n to m carbon atoms within the carbonyl-bound alkyl excluding the carbonyl carbon atom itself.
  • Suitable solvents S are mixtures of from 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5.
  • Suitable aprotic organic solvents comprise dichloromethane, methyl terf-butyl ether, tetrahydrofuran, acetonitrile, 1 ,4-Dioxane, ethylene glycol dimethyl ether, methyl isobutyl ketone, terf-Butanol, methyl ethyl ketone, acetone or mixtures thereof.
  • terf-Butanol is considered as an aprotic organic solvent.
  • a suitable buffer in the context of the present invention is phosphate buffer.
  • suitable buffering agents are well known in the art. Suitable buffering agents comprise TAPSO (3-[N-Tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic Acid), HEPES (4-2-hydroxyethyl-1 -piperazineethanesulfonic acid), TES (2- ⁇ [tris(hydroxymethyl)methyl]amino ⁇ ethanesulfonic acid), MOPS (3-(N- morpholino)propanesulfonic acid).
  • the buffers of the present invention contain 1 mM of calcium chloride. Further, preferably, the buffers of the present invention contain 1 %(w/v) of urea.
  • Suitable temperatures ⁇ are temperatures selected in relation to ⁇ , the temperature optimum of the protease P employed.
  • ⁇ the temperature optimum of a protease P is the temperature where the protease is most efficient at cleaving amide bonds in aqueous buffer.
  • the temperature optimum ⁇ is known for a number of proteases and can thus be determined from the literature by a person of skill.
  • the temperature optimum ⁇ of a protease P can be determined by a person of skill in the art with experiments regarding the temperature dependence of the velocity of proteolysis reactions involving model substrates of the respective protease.
  • Suitable temperatures ⁇ for performing the processes of the present invention are selected in the range from ( ⁇ - 50°C) to ( ⁇ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the
  • the process of the present invention is performed with the aid of a protease P.
  • the protease P can be any protease that is capable of forming the corresponding amide bond under the reaction conditions of the process of the present invention.
  • a person of skill in the art can for example perform an experiment analogous to examples 2, 3.1 1 or 3.12 as presented herein.
  • serine proteases and cysteine proteases are well suited for performing the process of the present invention, while aspartic acid proteases and metalloproteases are less/not suitable for performing the process of the present invention.
  • the protease P is a serine protease or a cysteine protease.
  • the protease P is a subtil isin-like serine protease (subtilisin-like serine proteases are defined in Siezen RJ and Leunissen JAM (1997) Protein Science 6: 501-523).
  • the protease P is selected from Achromopeptidase from Achromobacter lyticus, Ficin from fig tree latex, Papain from papaya latex, Protease (Subtilisin Carlsberg) from Bacillus licheniformis, Alcalase CLEA (Subtilisin) from Bacillus licheniformis, Protease from Streptomyces griseus, Proteinase K from Tritirachium album, Trypsin from bovine pancreas, a- Chymotrypsin from bovine pancreas, Clostripain from Clostridium histolyticum, Protease P "Amano" 6SD from Aspergillus melleus.
  • the protease P is Subtilisin, i.e. EC 3.4.21 .62 according to IUBMB nomenclature.
  • Reaction products according to formula (I) can be isolated from the reaction mixture according to standard procedures well known to a person of skill.
  • An exemplary procedure would be performed as follows: An amount of water about equal to the volume of the reaction mixture is added to the reaction mixture and the pH is adjusted to 1 -2 by addition of cone. HCI. The bulk of organic solvents is distilled off. The aqueous phase is then separated and washed with isopropyl acetate. The organic phases are discarded. The aqueous phase is concentrated and an amount of isopropyl acetate about equal to the volume of the concentrated aqueous phase is added and the pH is adjusted to 10-1 1 by addition of NaOH solution. Subsequently phase separation is performed at 70 °C.
  • the organic phase is separated and washed with water at 70 °C.
  • the organic phases are discarded.
  • the combined aqueous phases are cooled to 0 °C and the precipitate is filtered off, washed with cold isopropyl acetate and dried at 60 °C in vacuo.
  • L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl.
  • L is selected from C6-C12 linear alkyl, 1 ,4-dimethylcyclohexyl, xylene.
  • L is selected from C2-C20 alkyl.
  • R A is selected from C2-C20 alkyl, C7-C20 alkylaryl.
  • R A is selected from C2-C20 alkyl.
  • R 1 is selected from hydrogen atom, Ci-C 4 alkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl.
  • R 1 is selected from a hydrogen atom, an n-butyl group, a f-butyl group, a propyl group, a cyclopropyl group, an ethyl group, or one of the side chains of the amino acids alanine, valine, leucine, isoleucine, methionine, phenylalanine, tyrosine, tryptophan, serine, threonine, glutamine, asparagine.
  • R 1 is selected from one of the side chains of amino acids alanine, valine, leucine, isoleucine, or phenylalanine.
  • side chain refers to the substituent group attached to the a-carbon atom of an ⁇ -amino acid.
  • the side chains are methyl, isopropyl, isobutyl, sec-butyl, 2- thiomethyl-ethyl, benzyl, 4-hydroxybenzyl, 3-methylindol, hydroxymethyl, 1 - hydroxyethyl, carboxamidoethyl, carboxamidomethyl.
  • R 1 is selected from Ci-C 4 alkyl.
  • S13 mixture of 95% (v/v) to 99% (v/v) acetonitrile and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8
  • S14 mixture of 95% (v/v) to 99% (v/v) 1 ,4-Dioxane and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8
  • S15 mixture of 95% (v/v) to 99% (v/v) 99% (v/v) ethylene glycol dimethyl ether and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH
  • the temperature ⁇ is selected in the range from ( ⁇ - 30°C) to ( ⁇ + 5°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the
  • the temperature ⁇ selected.
  • the temperature ⁇ is selected in the range from ( ⁇ - 10°C) to ( ⁇ + 5°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature ⁇ selected.
  • the temperature ⁇ is selected as 37°C.
  • the protease P is a serine protease or a cysteine protease.
  • the protease P is a subtil isin-like serine protease (subtilisin-like serine proteases are defined in Siezen RJ and Leunissen JAM (1997) Protein Science 6: 501-523).
  • the protease P is selected from Achromopeptidase from Achromobacter lyticus, Ficin from fig tree latex, Papain from papaya latex, Protease (Subtilisin Carlsberg) from Bacillus licheniformis, Alcalase CLEA (Subtilisin) from Bacillus licheniformis, Protease from Streptomyces griseus, Proteinase K from Tritirachium album, Trypsin from bovine pancreas, a-Chymotrypsin from bovine pancreas, Clostripain from Clostridium histolyticum, Protease P "Amano" 6SD from Aspergillus melleus.
  • the protease P is Subtilisin, i.e. EC 3.4.21 .62 according to lUBMB nomenclature.
  • L selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 selected from hydrogen atom, Ci-C 4 alkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
  • one of X 1 , X 2 is nitrogen, the other is carbon,
  • the protease P is a serine protease or a cysteine protease.
  • L selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 selected from hydrogen atom, Ci-C 4 alkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
  • one of X 1 , X 2 is nitrogen, the other is carbon,
  • protease P is a subtil isin-like serine protease.
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 selected from hydrogen atom, Ci-C 4 alkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
  • X 1 is carbon and X 2 is nitrogen
  • the solvent S selected from S2 mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8
  • S3 mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S4 mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S5 mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • the protease P is a serine protease or a cysteine protease.
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 selected from hydrogen atom, Ci-C 4 alkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
  • X 1 is carbon and X 2 is nitrogen
  • the solvent S selected from S2 mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8
  • S3 mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S4 mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S5 mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • protease P is a subtil isin-like serine protease.
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 and R 2 independently selected from hydrogen atom, Ci-C 4 alkyl, Ci- C 4 hydroxyalkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C 4 -C2o alkyl heteroaryl,
  • one of X 1 , X 2 is nitrogen, the other is carbon,
  • X selected from -OH, -NH 2 , -NHR 3 , -NR 3 R 4 ;
  • R 3 and R 4 independently selected from C1-C6 alkyl and C 7 -C20 alkylaryl;
  • n selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10;
  • the protease P is a serine protease or a cysteine protease.
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 and R 2 independently selected from hydrogen atom, Ci-C 4 alkyl, Ci- C 4 hydroxyalkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C 4 -C2o alkyl heteroaryl,
  • one of X 1 , X 2 is nitrogen, the other is carbon,
  • X selected from -OH, -NH 2 , -NHR 3 , -NR 3 R 4 ;
  • R 3 and R 4 independently selected from C1-C6 alkyl and C7-C20 alkylaryl; and with
  • n selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10;
  • protease P is a subtil isin-like serine protease.
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 and R 2 independently selected from hydrogen atom, Ci-C 4 alkyl, Ci- C 4 hydroxyalkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C 4 -C2o alkylheteroaryl,
  • X 1 is carbon and X 2 is nitrogen
  • n 0, 1 , 2, 3,
  • the solvent S selected from S2 mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8
  • S3 mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S4 mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S5 mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • the protease P is a serine protease or a cysteine protease.
  • R A selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
  • R 1 and R 2 independently selected from hydrogen atom, Ci-C 4 alkyl, Ci- C 4 hydroxyalkyl, Ci-C 4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C 4 -C2o alkyl heteroaryl,
  • X 1 is carbon and X 2 is nitrogen
  • n 0, 1 , 2, 3,
  • the solvent S selected from S2 mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8
  • S3 mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S4 mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • S5 mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5
  • protease P is a subtilisin-like serine protease.
  • R 2 is selected from a hydrogen atom or one of the side chains of amino acids alanine, valine, leucine, isoleucine, methionine, phenylalanine, tyrosine, tryptophan, serine, threonine, glutamine, asparagine.
  • R 2 is selected from one of the side chains of amino acids alanine, valine, leucine, isoleucine, or phenylalanine.
  • the expression “side chain” refers to the substituent group attached to the a-carbon atom of an ⁇ -amino acid.
  • the side chains are methyl, isopropyl, isobutyl, sec-butyl, 2-thiomethyl-ethyl, benzyl, 4-hydroxybenzyl, 3-methylindol, hydroxymethyl, 1 -hydroxyethyl,
  • ester substrates The amount of ester substrates, mono- and di-amide products and hydrolysis byproducts were measured by HPLC using a C18 column and acetonitrile /phosphate buffer pH2.3 as solvent.
  • Isonicotinoyl-L-valine methylester to Isonicotinoyl-L-valine and of Z-L-valine methylester to Z-L-valine was analysed after 22 hours by HPLC.
  • Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of Isonicotinoyl-L-valine methylester and 950-990 ⁇ acetonitrile, depending on the volume of buffer were prepared.
  • 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10-50 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and l OOOrpm.
  • Substrate mixtures containing 225 ⁇ of 1 ,12-Diaminododecane, 500 ⁇ of Isonicotinoyl-L-valine methylester, the desired amount of additive and 950 ⁇ (with DMSO) or 990 ⁇ (with Urea) acetonitrile were prepared.
  • 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and l OOOrpm.
  • a substrate mixture containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of Isonicotinoyl-L-valine methylester and 990 ⁇ acetonitrile was prepared.
  • 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at different temperatures and 1000rpm.
  • Substrate mixtures containing the desired amounts of 1 ,12-Diaminododecane and Isonicotinoyl-L-valine methylester and 950 ⁇ acetonitrile were prepared.
  • licheniformis preparation dissolved in 50 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added to the substrate mixture and the vials were shaken for 24h at 37°C and 1000rpm.
  • a substrate mixture containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of Isonicotinoyl-L-valine methylester and 990 ⁇ acetonitrile was prepared.
  • the desired amount of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and 10 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added. The substrate mixture was added and the vials were shaken for 24h at 37°C and l OOOrpm.
  • a substrate mixture containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of Isonicotinoyl-L-valine methylester and 950 ⁇ acetonitrile was prepared.
  • the desired amount of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and 50 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added. The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.
  • Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of the desired Isonicotinoyl-L-valine ester and 990 ⁇ acetonitrile were prepared.
  • 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.
  • Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of the desired N-protected/acylated L-valine methylester and 990 ⁇ acetonitrile were prepared.
  • 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.
  • Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500 ⁇ of the desired N-protected/acylated L-valine phenylester and 990 ⁇ acetonitrile were prepared.
  • 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10 ⁇ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention is concerned with processes for the enzymatic formation of amide bonds. More specifically the invention is concerned with the formation of amide bonds between amino acid esters acylated on the amino terminus to nicotinic acid or isonicotinic acid and amino compounds with the aid of proteases. The invention provides processes for amide formation employing amino acid esters, connected to nicotinoyl- or isonicotinoyl-groups via an amide bond on the amino terminus, that are more efficient than processes for amide formation employing amino acid esters carrying standard protecting groups such as benzoyl or Z on their amino terminus. In one aspect therefore, the present invention, further, relates to the protease mediated synthesis of organogellant compounds (OG) as depicted below wherein L is a linking moiety of molecular weight from 14 g/mol to 500 g/mol, one of X1, X2 is nitrogen and the other is carbon, and wherein R1 are sidechain substituents.

Description

Process for the Enzymatic Formation of Amide Bonds
The present invention is concerned with the formation of amide bonds with the aid of proteases in general. One aspect of the present invention, further, relates to the protease mediated synthesis of organogellant compounds (OG) as depicted below
wherein L is a linking moiety of molecular weight from 14 g/mol to 500 g/mol, one of X1, X2 is nitrogen and the other is carbon, and wherein R1 are sidechain substituents.
Organogellant compounds as depicted above are known in the art to serve as gellants to thicken liquid compositions. Such gellants have, for example, been described in WO 201 1 /1 12912 A1 and WO 201 1 /1 12887 A1 .
Organogellant compounds also termed organogellants herein, in general are used to provide structure and a pleasant texture to liquid consumer products such as, for example, liquid detergent compositions. Furthermore, organogellants can be used to stabilize other components within such compositions such as, for example, enzymes and bleaches. However, organogellants need to be selected carefully for their respective application in order to prevent incompatibilities between organogellant and other components as well as unwanted side effects such as clouding.
Organogellants of the present invention offer significant advantages over other gellants currently in use, such as being compatible with a broad range of consumer products as well as not affecting product clarity.
Synthetic access to organogellants is described in WO 201 1/1 12887 A1 . However, the syntheses described therein are expensive and time-consuming. Accordingly, there is a need in the field for cheaper and faster access to organogellants.
Significant efforts have been devoted in the past to the development of methods for amide bond-formation with the aid of proteases, also termed as "reverse proteolysis" (cf. e.g. Bordusa F (2002) Chem Rev (102) 4817-4867). Typically in a reverse proteolysis reaction a carboxyester compound is reacted with an amino compound in the presence of a protease which catalyses formation of the amide bond. Importantly, if the carboxyester compound itself contains an amino function, as in the case of amino acid esters, care has to be taken to protect or acylate this amino group in order to prevent polymerization of the amino acid.
As presented herein, it was now found that the choice of the acyl-group on the amino terminus of amino acid esters has significant influence on the coupling yield of protease mediated amide bond formig reactions employing such amino-acylated amino acid esters.
More specifically, it was found that amino acid esters connected via an amide bond on their amino terminus to nicotinic acid (pyridine-3-carboxylic acid )or isonicotinic acid (pyridine-4-carboxylic acid ) result in better yields during protease mediated coupling to amino compounds than amino acid esters carrying other moieties on their amino terminus such as for example typical protecting groups Benzoyl- or Z- (Carboxybenzyl).
Protease mediated amide bond formation employing amino acid esters connected via an amide bond on their amino terminus to nicotinic acid or isonicotinic acid, accordingly, provides efficient access to organogellants and peptides.
Accordingly, the present invention provides processes for the manufacture of compounds according to formula I
(I)
comprising reacting a compound of formula II with a compound of formula III in a solvent S, at a Temperature Θ, in the presence of a protease P, wherein compound II is defined as compound II = T or compound II = Q, with
L
H2N NH2
(II = T)
and
(II = Q) and
compound (III) is defined as
wherein
M is selected from
, when compound II = T; and
, when compound II = Q;
R1 and R2 are independently selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20
alkylhydroxyaryl, C4-C2o alkyl heteroaryl, Ci-C4 alkyl-C(O)Y; one of X1, X2 is nitrogen, the other is carbon;
L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl;
X and Y are independently selected from -OH, -NH2, -NHR3, -NR3R4;
R3 and R4 are independently selected from C1-C6 alkyl and C7-C20 alkylaryl; n is selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20;
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl. The following definitions are used in the context of the present invention: An alkyl is a linear, branched, or cyclic hydrocarbon chain. It may also be a combination of linear, branched, and cyclic hydrocarbon chains. A Cn-Cm alkyl is an alkyl having n to m carbon atoms.
An aryl is an aromatic hydrocarbon. An aryl may be monocyclic or polycyclic. In the case of polycyclic aryls, the individual aromatic rings may be fused or may be connected by single carbon-carbon bonds. Examples of suitable aryls are phenyl, biphenyl, naphtyl, anthryl, or phenanthryl. A Cn-Cm aryl is an aryl having n to m carbon atoms.
A heteroaryl is an aromatic hydrocarbon that contains 1 to 4 heteroatoms, preferably 1 to 2 heteroatoms. Heteroatoms are independently selected from nitrogen, oxygen, sulfur. A heteroaryl may be monocyclic or polycyclic. A heteroaryl may be attached to the main molecule through any of its carbon or nitrogen atoms. A Cn-Cm heteroaryl is a heteroaryl having n to m carbon atoms and 1 to 4 heteroatoms.
An alkylaryl is an aryl that is substituted with one or more alkyls. An alkylaryl may be attached to the remainder of the molecule through any of its alkyl or aryl carbon atoms. A Cn-Cm alkylaryl contains n to m carbon atoms.
An a Iky I heteroaryl is a heteroaryl that is substituted with one or more alkyls. The alkyl substituents may be attached to the heteroaryl through any of the carbon- or heteroatoms of the heteroaryl. The alkylheteroaryl group may be attached to the remainder of the molecule through any of the alkyl carbon atoms and/or the heteroaryl carbon- or heteroatoms.
A hydroxyalkyl is an alkyl carrying one or more hydroxyl groups. A Cn-Cm
hydroxyalkyl group contains n to m carbon atoms.
A thioether is a moiety wherein two alkyls are linked by a thioether bond. A Cn-Cm thioether group contains n to m carbon atoms in total. The thioether group may be attached to the remainder of the molecule through any of its carbon atoms.
An alkylhydroxyaryl is an alkylaryl, carrying hydroxyl groups on any of the aryl carbon atoms. The alkylhydroxyaryl group may be attached to the remainder of the molecule through any of its alkyl and/or aryl carbon atoms. A Cn-Cm alkylhydroxyaryl contains n to m carbon atoms.
An alkyl-C(O)Y is an alkyl carrying a C(O)Y-group, wherein C(O) is a carbonyl function and Y is selected from -OH, -NH2, -NHR3, -NR3R4; and wherein R3 and R4 are independently selected from C1-C6 alkyl and C7-C20 alkylaryl. A Cn-Cm alkyl- C(O)Y contains n to m carbon atoms within the carbonyl-bound alkyl excluding the carbonyl carbon atom itself.
The process of the present invention is performed in a solvent S. Suitable solvents S are mixtures of from 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5.
Suitable aprotic organic solvents comprise dichloromethane, methyl terf-butyl ether, tetrahydrofuran, acetonitrile, 1 ,4-Dioxane, ethylene glycol dimethyl ether, methyl isobutyl ketone, terf-Butanol, methyl ethyl ketone, acetone or mixtures thereof. In the context of the present invention terf-Butanol is considered as an aprotic organic solvent.
A suitable buffer in the context of the present invention is phosphate buffer. Other suitable buffering agents are well known in the art. Suitable buffering agents comprise TAPSO (3-[N-Tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic Acid), HEPES (4-2-hydroxyethyl-1 -piperazineethanesulfonic acid), TES (2- {[tris(hydroxymethyl)methyl]amino}ethanesulfonic acid), MOPS (3-(N- morpholino)propanesulfonic acid). Preferably, the buffers of the present invention contain 1 mM of calcium chloride. Further, preferably, the buffers of the present invention contain 1 %(w/v) of urea.
The process of the present invention is performed at a temperature Θ. Suitable temperatures Θ are temperatures selected in relation to ΘΟΡΤ, the temperature optimum of the protease P employed. ΘΟΡΤ, the temperature optimum of a protease P is the temperature where the protease is most efficient at cleaving amide bonds in aqueous buffer. The temperature optimum ΘΟΡΤ is known for a number of proteases and can thus be determined from the literature by a person of skill. Alternatively, the temperature optimum ΘΟΡΤ of a protease P can be determined by a person of skill in the art with experiments regarding the temperature dependence of the velocity of proteolysis reactions involving model substrates of the respective protease. Suitable temperatures Θ for performing the processes of the present invention are selected in the range from (ΘΟΡΤ - 50°C) to (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the
temperature Θ selected.
The process of the present invention is performed with the aid of a protease P. The protease P can be any protease that is capable of forming the corresponding amide bond under the reaction conditions of the process of the present invention. In order to determine suitability of a protease for use in the process of the present invention a person of skill in the art can for example perform an experiment analogous to examples 2, 3.1 1 or 3.12 as presented herein. As shown experimentally (cf. Example 2) serine proteases and cysteine proteases are well suited for performing the process of the present invention, while aspartic acid proteases and metalloproteases are less/not suitable for performing the process of the present invention. Therefore, in a preferred embodiment of the present invention the protease P is a serine protease or a cysteine protease. In another preferred embodiment of the present invention the protease P is a subtil isin-like serine protease (subtilisin-like serine proteases are defined in Siezen RJ and Leunissen JAM (1997) Protein Science 6: 501-523). In another preferred embodiment of the present invention the protease P is selected from Achromopeptidase from Achromobacter lyticus, Ficin from fig tree latex, Papain from papaya latex, Protease (Subtilisin Carlsberg) from Bacillus licheniformis, Alcalase CLEA (Subtilisin) from Bacillus licheniformis, Protease from Streptomyces griseus, Proteinase K from Tritirachium album, Trypsin from bovine pancreas, a- Chymotrypsin from bovine pancreas, Clostripain from Clostridium histolyticum, Protease P "Amano" 6SD from Aspergillus melleus. In another preferred embodiment of the present invention the protease P is Subtilisin, i.e. EC 3.4.21 .62 according to IUBMB nomenclature. Compounds according to formula (ll=T) are commercially available, compounds according to formula (ll=Q) and formula (III) are accessible via standard peptide chemistry well known to a person of skill in the art.
Reaction products according to formula (I) can be isolated from the reaction mixture according to standard procedures well known to a person of skill. An exemplary procedure would be performed as follows: An amount of water about equal to the volume of the reaction mixture is added to the reaction mixture and the pH is adjusted to 1 -2 by addition of cone. HCI. The bulk of organic solvents is distilled off. The aqueous phase is then separated and washed with isopropyl acetate. The organic phases are discarded. The aqueous phase is concentrated and an amount of isopropyl acetate about equal to the volume of the concentrated aqueous phase is added and the pH is adjusted to 10-1 1 by addition of NaOH solution. Subsequently phase separation is performed at 70 °C. The organic phase is separated and washed with water at 70 °C. The organic phases are discarded. The combined aqueous phases are cooled to 0 °C and the precipitate is filtered off, washed with cold isopropyl acetate and dried at 60 °C in vacuo.
In a preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and
L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl.
In another preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and
L is selected from C6-C12 linear alkyl, 1 ,4-dimethylcyclohexyl, xylene.
In another preferred embodiment of the present invention compound II is selected from compound II = T with compound II = T selected from the following list of diamines
In another preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and
L is selected from C2-C20 alkyl.
In another preferred embodiment of the present invention RA is selected from C2-C20 alkyl, C7-C20 alkylaryl.
In another preferred embodiment of the present invention RA is selected from C2-C20 alkyl.
In another preferred embodiment of the present invention R1 is selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl.
In another preferred embodiment of the present invention R1 is selected from a hydrogen atom, an n-butyl group, a f-butyl group, a propyl group, a cyclopropyl group, an ethyl group, or one of the side chains of the amino acids alanine, valine, leucine, isoleucine, methionine, phenylalanine, tyrosine, tryptophan, serine, threonine, glutamine, asparagine. In another particularly preferred embodiment, R1 is selected from one of the side chains of amino acids alanine, valine, leucine, isoleucine, or phenylalanine. Here, the expression "side chain" refers to the substituent group attached to the a-carbon atom of an α-amino acid. For the above- mentioned amino acids, the side chains are methyl, isopropyl, isobutyl, sec-butyl, 2- thiomethyl-ethyl, benzyl, 4-hydroxybenzyl, 3-methylindol, hydroxymethyl, 1 - hydroxyethyl, carboxamidoethyl, carboxamidomethyl.
In another preferred embodiment of the present invention R1 is selected from Ci-C4 alkyl.
In another preferred embodiment of the present invention the solvent S is selected from S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4-Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) tert- Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5.
In another preferred embodiment of the present invention the solvent S is selected from S7 = mixture of 95% (v/v) to 99% (v/v) aprotic organic solvent and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S8 = mixture of 95% (v/v) to 99% (v/v) acetonitrile and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S9 = mixture of 95% (v/v) to 99% (v/v) 1 ,4-Dioxane and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S10 = mixture of 95% (v/v) to 99% (v/v) ethylene glycol dimethyl ether and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S1 1 = mixture of 95% (v/v) to 99% (v/v) terf-Butanol and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5.
In another preferred embodiment of the present invention the solvent S is selected from S12 = mixture of 95% (v/v) to 99% (v/v) aprotic organic solvent and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S13 = mixture of 95% (v/v) to 99% (v/v) acetonitrile and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S14 = mixture of 95% (v/v) to 99% (v/v) 1 ,4-Dioxane and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S15 = mixture of 95% (v/v) to 99% (v/v) ethylene glycol dimethyl ether and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S16 = mixture of 95% (v/v) to 99% (v/v) terf-Butanol and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8.
In a preferred embodiment of the present invention the temperature Θ is selected in the range from (ΘΟΡΤ - 30°C) to (ΘΟΡΤ + 5°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the
temperature Θ selected. In another preferred embodiment of the present invention the temperature Θ is selected in the range from (ΘΟΡΤ - 10°C) to (ΘΟΡΤ + 5°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected. In another preferred embodiment of the present invention the temperature Θ is selected as 37°C.
In a preferred embodiment of the present invention the protease P is a serine protease or a cysteine protease. In another preferred embodiment of the present invention the protease P is a subtil isin-like serine protease (subtilisin-like serine proteases are defined in Siezen RJ and Leunissen JAM (1997) Protein Science 6: 501-523). In another preferred embodiment of the present invention the protease P is selected from Achromopeptidase from Achromobacter lyticus, Ficin from fig tree latex, Papain from papaya latex, Protease (Subtilisin Carlsberg) from Bacillus licheniformis, Alcalase CLEA (Subtilisin) from Bacillus licheniformis, Protease from Streptomyces griseus, Proteinase K from Tritirachium album, Trypsin from bovine pancreas, a-Chymotrypsin from bovine pancreas, Clostripain from Clostridium histolyticum, Protease P "Amano" 6SD from Aspergillus melleus. In another preferred embodiment of the present invention the protease P is Subtilisin, i.e. EC 3.4.21 .62 according to lUBMB nomenclature.
In another preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and with
M selected from
and with
L selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and with
one of X1, X2 is nitrogen, the other is carbon,
and with
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a serine protease or a cysteine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and with
M selected from
and with
L selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and with
one of X1 , X2 is nitrogen, the other is carbon,
and with
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a subtil isin-like serine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and with M selected from
and with
L selected from C2-C20 alkyl,
and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and with
X1 is carbon and X2 is nitrogen,
and with
the solvent S selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a serine protease or a cysteine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = T with
(II = T),
and with
M selected from
R1 O
and with
L selected from C2-C20 alkyl,
and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and with
X1 is carbon and X2 is nitrogen,
and with
the solvent S selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a subtil isin-like serine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = Q wit
= Q).
and with
M selected from and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 and R2 independently selected from hydrogen atom, Ci-C4 alkyl, Ci- C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkyl heteroaryl,
and with
one of X1 , X2 is nitrogen, the other is carbon,
and with
X selected from -OH, -NH2, -NHR3, -NR3R4;
and with
R3 and R4 independently selected from C1-C6 alkyl and C7-C20 alkylaryl; and with
n selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10;
and with
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a serine protease or a cysteine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = Q wit
(II = Q)
and with
M selected from and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 and R2 independently selected from hydrogen atom, Ci-C4 alkyl, Ci- C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkyl heteroaryl,
and with
one of X1 , X2 is nitrogen, the other is carbon,
and with
X selected from -OH, -NH2, -NHR3, -NR3R4;
and with
R3 and R4 independently selected from C1-C6 alkyl and C7-C20 alkylaryl; and with
n selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10;
and with
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a subtil isin-like serine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = Q wit
= 0),
and with
M selected from and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 and R2 independently selected from hydrogen atom, Ci-C4 alkyl, Ci- C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkylheteroaryl,
and with
X1 is carbon and X2 is nitrogen,
and with
X selected from -OH,
and with
n selected from 0, 1 , 2, 3,
and with
the solvent S selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a serine protease or a cysteine protease.
In another preferred embodiment of the present invention compound II is selected from compound II = Q wit
(N = Q).
and with
M selected from
and with
RA selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and with
R1 and R2 independently selected from hydrogen atom, Ci-C4 alkyl, Ci- C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkyl heteroaryl,
and with
X1 is carbon and X2 is nitrogen,
and with
X selected from -OH,
and with
n selected from 0, 1 , 2, 3,
and with
the solvent S selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and with
the temperature Θ selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and with
the protease P is a subtilisin-like serine protease.
In another preferred embodiment of the present invention R2 is selected from a hydrogen atom or one of the side chains of amino acids alanine, valine, leucine, isoleucine, methionine, phenylalanine, tyrosine, tryptophan, serine, threonine, glutamine, asparagine. In another particularly preferred embodiment, R2 is selected from one of the side chains of amino acids alanine, valine, leucine, isoleucine, or phenylalanine. Here, the expression "side chain" refers to the substituent group attached to the a-carbon atom of an α-amino acid. For the above-mentioned amino acids, the side chains are methyl, isopropyl, isobutyl, sec-butyl, 2-thiomethyl-ethyl, benzyl, 4-hydroxybenzyl, 3-methylindol, hydroxymethyl, 1 -hydroxyethyl,
carboxamidoethyl , carboxam idomethyl .
Examples
1 . HPLC analysis
The amount of ester substrates, mono- and di-amide products and hydrolysis byproducts were measured by HPLC using a C18 column and acetonitrile /phosphate buffer pH2.3 as solvent.
2. Enzyme screening via hydrolysis
10U of enzyme preparation was weighed in 1 .5ml vials and dissolved in 848μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) or phosphate buffer pH 2.5 (containing 250mM potassium phosphate, 500mM citric acid and 1 mM calcium chloride). 152μΙ solution of 100mM Isonicotinoyl- L-valine methylester or 100 mM Z-L-valine methylester, dissolved in acetonitrile was added and the vials were shaken for 22h at 25°C or 37°C. Conversion of
Isonicotinoyl-L-valine methylester to Isonicotinoyl-L-valine and of Z-L-valine methylester to Z-L-valine was analysed after 22 hours by HPLC.
Enzyme Protease Type Reaction Conversion Conversion parameter to to
IsonicotinoyI- Z-L-valine
L-valine [mM] [mM]
Achromopeptidase Serine protease pH7.5 / 80.1 63,4 from Achromobacter 37°C
lyticus
Ficin from fig tree Cysteine pH7.5 / 98.3 95,8 latex protease 37°C
Papain from papaya Cysteine pH7.5 / 91 .0 62,5 latex protease 25°C
Protease from Aspartatic acid pH2.5 / 4.9 3,0 Aspergillus saitoi protease 37°C
Protease (Subtil isin Serine protease pH7.5 / 100 93,5 Carlsberg) from 37°C
Bacillus licheniformis
Alcalase CLEA Serine protease pH7.5 / 100 98,5 (Subtilisin) from 37°C
Bacillus licheniformis
Protease from Serine protease pH7.5 / 89.0 61 ,6 Streptomyces 37°C
griseus (Streptogrisin B)
Proteinase K from Serine protease pH7.5 / 99.6 91 ,3 Tritirachium album 37°C
Trypsin from bovine Serine protease pH7.5 / 22.6 3,5 pancreas 25°C
a-Chymotrypsin from Serine protease pH7.5 / 91 .6 88,5 bovine pancreas 25°C
Clostripain from Cysteine pH7.5 / 27.6 7,3
Clostridium protease 25°C
histolyticum
Pepsin from porcine Aspartatic acid pH2.5 / 1 .9 1 ,7 gastric mucosa protease 37°C
Thermolysin from Metal loprotease pH7.5 / 5.2 4,0 Bacillus 37°C
thermoproteolyticus
rokko
Protease P "Amano" Serine protease pH7.5 / 39.8 20,1 6SD from Aspergillus 37°C
melleus (Seaprose)
No enzyme (blank) pH2.5 / <1 <1
37°C
No enzyme (blank) pH7.5 / <1 <1
37°C
3. Reaction of Isonicotinoyl-L-valine ester and 1 ,12-Diaminododecane to N,N-Bis- (Isonicotinoyl-L-valovD-l ,12-diaminododecane
3.1 Comparison of different enzymes
500μηηοΙβ of 1 ,12-Diaminododecane was weighed in 1 .5ml vials and dissolved in 950μΙ acetonitrile solution, containing l OO mole of Isonicotinoyl-L-valine methylester. 1 .Omg of enzyme preparation, dissolved in 50μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added and the vials were shaken for 24h at 37°C and 1000rpm. Conversion of Isonicotinoyl-L-valine methylester to the respective mono- and diamide was analysed after 24 hours by HPLC.
3.2 Comparison of different solvents
225 mole of 1 ,12-Diaminododecane and 500μηηοΙβ of Isonicotinoyl-L-valine methylester were weighed in 1 .5ml vials and dissolved in 950μΙ solvent. 5. Omg of Subtilisin Carlsberg from Bacillus licheniformis preparation, dissolved in 50μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added and the vials were shaken for 24h at 37°C and l OOOrpm.
Conversion of Isonicotinoyl-L-valine methylester to the respective mono- and diamide was analysed after 24 hours by HPLC.
3.3 Comparison of different amounts of buffer
Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of Isonicotinoyl-L-valine methylester and 950-990μΙ acetonitrile, depending on the volume of buffer were prepared. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10-50μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and l OOOrpm.
3.4 Comparison of different additives
Substrate mixtures containing 225μηηοΙβ of 1 ,12-Diaminododecane, 500μηηοΙβ of Isonicotinoyl-L-valine methylester, the desired amount of additive and 950μΙ (with DMSO) or 990μΙ (with Urea) acetonitrile were prepared. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and l OOOrpm.
3.5 Comparison of different temperatures using 95% acetonitrile with 5% buffer as solvent
225 mole of 1 ,12-Diaminododecane and 500μηηοΙβ of Isonicotinoyl-L-valine methylester were weighed in 1 .5ml vials and dissolved in 950μΙ acetonitrile. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation, dissolved in 50μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added and the vials were shaken for 24h at different temperatures and l OOOrpm.
3.6 Comparison of different temperatures using 99% acetonitrile with 1 % buffer as solvent
A substrate mixture containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of Isonicotinoyl-L-valine methylester and 990μΙ acetonitrile was prepared. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at different temperatures and 1000rpm.
3.7 Comparison of different substrate concentrations
Substrate mixtures containing the desired amounts of 1 ,12-Diaminododecane and Isonicotinoyl-L-valine methylester and 950μΙ acetonitrile were prepared. For 1200mM ester and saturated di-amine the mixture was filtrated after stirring 18h at 50°C to remove undissolved di-amine. 5.0mg of Subtilisin Carlsberg from Bacillus
licheniformis preparation, dissolved in 50μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added to the substrate mixture and the vials were shaken for 24h at 37°C and 1000rpm.
Conversion to Conversion to
Concentration Concentration of di-amide mono-amide of ester [mM] di-amine [mM] [mM/24h] [mM/24h]
100 50 0.1 2.1
500 225 2.3 60.4
max 389.6
1200 171 .9
(saturated) 9.5 3.8 Comparison of different enzyme concentrations using 99% acetonitrile with 1 % buffer as solvent
A substrate mixture containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of Isonicotinoyl-L-valine methylester and 990μΙ acetonitrile was prepared. The desired amount of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and 10μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added. The substrate mixture was added and the vials were shaken for 24h at 37°C and l OOOrpm.
3.9 Comparison different enzyme concentrations using 95% acetonitrile with 5% buffer as solvent
A substrate mixture containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of Isonicotinoyl-L-valine methylester and 950μΙ acetonitrile was prepared. The desired amount of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and 50μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride) was added. The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.
3.10 Comparison of different Isonicotinoyl-L-valine esters
Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of the desired Isonicotinoyl-L-valine ester and 990μΙ acetonitrile were prepared. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.
Conversion to Conversion to
di-amide mono-amide
Ester [mM/24h] [mM/24h]
-OtBu 0 2.0
-OMe 5.3 83.7
*) similar conversion wit hout enzyme
3.1 1 Comparison of different acyl/protection groups using the methylester as the substrate
Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of the desired N-protected/acylated L-valine methylester and 990μΙ acetonitrile were prepared. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.
3.12 Comparison of different acyl/protection groups using the phenylester as the substrate
Substrate mixtures containing 225 mole of 1 ,12-Diaminododecane, 500μηηοΙβ of the desired N-protected/acylated L-valine phenylester and 990μΙ acetonitrile were prepared. 5.0mg of Subtilisin Carlsberg from Bacillus licheniformis preparation was weighed in 1 .5ml vials and dissolved in 10μΙ phosphate buffer pH 7.5 (containing 250mM potassium phosphate and 1 mM calcium chloride). The substrate mixture was added and the vials were shaken for 24h at 37°C and 1000rpm.

Claims

Claims
Process for the manufacture of compounds according to formula I
(I)
comprising reacting a compound of formula II with a compound of formula in a solvent S, at a temperature Θ, in the presence of a protease P, wherein compound II is defined as compound II = T or compound II = Q, with
= T),
and
= Q).
and
compound (III) is defined as
wherein
M is selected from
und II = T; and
R1 and R2 are independently selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20
alkylhydroxyaryl, C4-C2o alkyl heteroaryl, Ci-C4 alkyl-C(O)Y; one of X1 , X2 is nitrogen, the other is carbon;
L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl;
X and Y are independently selected from -OH, -NH2, -NHR3, -NR3R4;
R3 and R4 are independently selected from C1-C6 alkyl and C7-C20 alkylaryl; n is selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20;
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl.
Process according to claim 1 , wherein compound II is selected from compound II = T with
(II = T),
and wherein
L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl.
3. Process according to claim 2, wherein L is selected from C2-C20 alkyl.
4. Process according to claims 1 to 3, wherein R1 is selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl.
5. Process according to claims 1 to 4, wherein R1 is selected from Ci-C4 alkyl.
6. Process according to claims 1 to 5, wherein the solvent S is selected from S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4-Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S7 = mixture of 95% (v/v) to 99% (v/v) aprotic organic solvent and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S8 = mixture of 95% (v/v) to 99% (v/v) acetonitrile and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S9 = mixture of 95% (v/v) to 99% (v/v) 1 ,4-Dioxane and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S10 = mixture of 95% (v/v) to 99% (v/v) ethylene glycol dimethyl ether and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S1 1 = mixture of 95% (v/v) to 99% (v/v) terf-Butanol and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S12 = mixture of 95% (v/v) to 99% (v/v) aprotic organic solvent and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S13 = mixture of 95% (v/v) to 99% (v/v) acetonitrile and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S14 = mixture of 95% (v/v) to 99% (v/v) 1 ,4-Dioxane and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S15 = mixture of 95% (v/v) to 99% (v/v) ethylene glycol dimethyl ether and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S16 = mixture of 95% (v/v) to 99% (v/v) terf-Butanol and 5% (v/v) to 1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8.
7. Process according to claims 1 to 6, wherein the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to θ = (ΘΟΡΤ + 10°C) or in the range from θ = (ΘΟΡΤ - 30°C) to θ = (ΘΟΡΤ + 5°C) or in the range from (ΘΟΡΤ - 10°C) to (ΘΟΡΤ + 5°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected.
8. Process according to claims 1 to 7, wherein the protease P is a serine
protease or a cysteine protease.
9. Process according to claims 1 to 8, wherein the protease P is a subtilisin- like serine protease.
Process according to claim 1 , wherein compound II is selected from compound II = T with and wherein
M is selected from
and wherein
L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 is selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and wherein
one of X1 , X2 is nitrogen, the other is carbon,
and wherein
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a serine protease or a cysteine protease.
11. Process according to claim 1 , wherein compound II is selected from
compound II = T with
(II = T),
and wherein M is selected from
and wherein
L is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 is selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and wherein
one of X1 , X2 is nitrogen, the other is carbon,
and wherein
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a subtilisin-like serine protease.
12. Process according to claim 1 , wherein compound II is selected from
compound II = T with and wherein
M is selected from
and wherein
L is selected from C2-C20 alkyl,
and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 is selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and wherein
X1 is carbon and X2 is nitrogen,
and wherein
the solvent S is selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a serine protease or a cysteine protease.
Process according to claim 1 , wherein compound II is selected from compound II = T with and wherein
M is selected from
and wherein
L is selected from C2-C20 alkyl,
and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 is selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl,
and wherein
X1 is carbon and X2 is nitrogen, and wherein
the solvent S is selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a subtil isin-like serine protease.
14. Process according to claim 1 , wherein compound II is selected from
compound II = Q with
= Q).
and wherein
M is selected from
and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 and R2 are independently selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkylheteroaryl,
and wherein one of X1, X2 is nitrogen, the other is carbon,
and wherein
X is selected from -OH, -NH2, -NHR3, -NR3R4;
and wherein
R3 and R4 are independently selected from C1-C6 alkyl and C7-C20 alkylaryl;
and wherein
n is selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10;
and wherein
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a serine protease or a cysteine protease.
15. Process according to claim 1 , wherein compound II is selected from
compound II = Q with
(II = Q)
and wherein
M is selected from
and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 and R2 are independently selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkyl heteroaryl,
and wherein one of X1, X2 is nitrogen, the other is carbon,
and wherein
X is selected from -OH, -NH2, -NHR3, -NR3R4;
and wherein
R3 and R4 are independently selected from C1-C6 alkyl and C7-C20 alkylaryl;
and wherein
n is selected from 0, 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10;
and wherein
the solvent S is S1 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a subtil isin-like serine protease.
16. Process according to claim 1 , wherein compound II is selected from
compound II = Q with
= 0),
and wherein
M is selected from
and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl, and wherein
R1 and R2 are independently selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkyl heteroaryl,
and wherein X1 is carbon and X2 is nitrogen,
and wherein
X is selected from -OH,
and wherein
n is selected from 0, 1 , 2, 3,
and wherein
the solvent S is selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a serine protease or a cysteine protease.
17. Process according to claim 1 , wherein compound II is selected from
compound II = Q with
(II = Q)
and wherein
M is selected from
and wherein
RA is selected from C2-C20 alkyl, C6-C20 aryl, C7-C20 alkylaryl and wherein
R1 and R2 are independently selected from hydrogen atom, Ci-C4 alkyl, Ci-C4 hydroxyalkyl, Ci-C4 thioether, C6-C20 aryl, C7-C20 alkylaryl, C7-C20 alkylhydroxyaryl, C4-C2o alkyl heteroaryl,
and wherein
X1 is carbon and X2 is nitrogen,
and wherein
X is selected from -OH,
and wherein
n is selected from 0, 1 , 2, 3,
and wherein
the solvent S is selected from S2 = mixture of 90% (v/v) to 99.9% (v/v) aprotic organic solvent and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 7 and pH 8, S3 = mixture of 90% (v/v) to 99.9% (v/v) acetonitrile and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S4 = mixture of 90% (v/v) to 99.9% (v/v) 1 ,4- Dioxane and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S5 = mixture of 90% (v/v) to 99.9% (v/v) ethylene glycol dimethyl ether and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5, S6 = mixture of 90% (v/v) to 99.9% (v/v) terf-Butanol and 10% (v/v) to 0.1 % (v/v) aqueous buffer at a pH between pH 6.5 and pH 8.5,
and wherein
the temperature Θ is selected in the range from θ = (ΘΟΡΤ - 50°C) to Θ = (ΘΟΡΤ + 10°C) with the proviso that the reaction mixture used for performing the process should be in the liquid state at the temperature Θ selected,
and wherein
the protease P is a subtil isin-like serine protease.
EP13773248.3A 2012-11-01 2013-10-04 Process for the enzymatic formation of amide bonds Withdrawn EP2914734A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261721445P 2012-11-01 2012-11-01
PCT/EP2013/070714 WO2014067746A1 (en) 2012-11-01 2013-10-04 Process for the enzymatic formation of amide bonds

Publications (1)

Publication Number Publication Date
EP2914734A1 true EP2914734A1 (en) 2015-09-09

Family

ID=49303984

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13773248.3A Withdrawn EP2914734A1 (en) 2012-11-01 2013-10-04 Process for the enzymatic formation of amide bonds

Country Status (3)

Country Link
EP (1) EP2914734A1 (en)
DE (1) DE112013005259T5 (en)
WO (1) WO2014067746A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11021514B2 (en) 2016-06-01 2021-06-01 Athira Pharma, Inc. Compounds
CN106366033B (en) * 2016-09-07 2019-05-07 南京理工大学 A kind of gemini structure supramolecular gel factor and preparation method thereof
WO2021194908A1 (en) * 2020-03-24 2021-09-30 Encodia, Inc. Modified dipeptide cleavases, uses thereof and related kits
US11427814B2 (en) 2019-03-26 2022-08-30 Encodia, Inc. Modified cleavases, uses thereof and related kits
BR112023018676A2 (en) 2021-03-18 2023-10-10 Seagen Inc ANTIBODY-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT OF A DISEASE OR CONDITION AND A CANCER, AND, LINDER-DRUG CONJUGATE COMPOSITION
EP4105335A1 (en) 2021-06-16 2022-12-21 Evonik Operations GmbH Enzymatic method for the production of l-glufosinate p-alkyl esters
WO2023174511A1 (en) 2022-03-14 2023-09-21 Evonik Operations Gmbh Enzymatic method for the production of l-glufosinate p-esters

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677427B1 (en) * 2000-06-13 2004-01-13 Hercules Incorporated Enzyme-catalyzed polyamides and compositions and processes of preparing and using the same
DE102004058073A1 (en) * 2004-12-01 2006-06-08 Basf Ag Process for the preparation of an aqueous polyamide dispersion
MX2012010572A (en) 2010-03-12 2012-10-09 Procter & Gamble Di-amido gellant for use in consumer product compositions.
US8222197B2 (en) 2010-03-12 2012-07-17 The Procter & Gamble Company Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2014067746A1 *

Also Published As

Publication number Publication date
WO2014067746A1 (en) 2014-05-08
DE112013005259T5 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
WO2014067746A1 (en) Process for the enzymatic formation of amide bonds
US12351780B2 (en) Peptide acetals for stabilising enzymes
Hernández et al. Mechanoenzymatic peptide and amide bond formation
FI102379B (en) Urethane-protected amino acid N-carboxyanhydrides
Falkiewicz et al. Synthesis of achiral and chiral peptide nucleic acid (PNA) monomers using Mitsunobu reaction
CN102216324B (en) Peptide Synthesis Using Enzymatic and Coupling Reactions
CA1059051A (en) Process for producing a peptide
JP5787278B2 (en) Method for producing peptide
JP5221336B2 (en) Process for producing γ-glutamylcysteine
Pearson et al. Photoswitch inhibitors of α-chymotrypsin—increased substitution and peptidic character in peptidomimetic boronate esters
Noguchi et al. Convenient peptide synthesis using unprotected α-amino acids containing another hydrophilic moiety under basic conditions
CA2509765A1 (en) Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them
Krix et al. Protease-catalyzed synthesis of new hydrophobic dipeptides containing non-proteinogenic amino acids
Kijima et al. Facile optical resolution of amino acid esters via hydrolysis by an industrial enzyme in organic solvents
JP4359142B2 (en) Enzymatic method for the preparation of substituted 2-amino-3- (2-amino-phenylsulfanyl) propionic acid
JP2641464B2 (en) Enzymatic peptide bond formation reaction
CA1337936C (en) Vibriolysin coupling process
EP2198037B1 (en) Chemo-enzymatic peptide synthesis via C-terminal ester interconversion
JP6031048B2 (en) Process for producing amino acid solids
Laumen et al. Easy access to enantiomerically pure nonproteinogenic amino acids
JP4856184B2 (en) Enzymatic conversion of oligopeptide amides to oligopeptide alkyl esters
TW200815370A (en) Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
Manzenrieder et al. Solid-Phase Synthesis of Phosphinic Dipepetide Isosteres and β Amino Acids via Activated N-Terminal Acrylamides
Midura-Nowaczek et al. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors
Nuijens et al. Enzymatic synthesis of amino acid and peptide C-terminal α-arylamides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150417

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151222